自发性脑出血患者的颅内压监测:系统综述与Meta分析
本系统综述与Meta分析纳入自发性脑出血患者,比较颅内压监测(ICPm)与未监测者的院内死亡、6个月死亡及6个月神经功能不良结局。ICPm组院内死亡率24.9% vs 34.1%(OR 0.51,95%CI 0.20-1.31,P=0.16),无统计学显著性;排除脑室内出血患者后院内死亡率23.5% vs 43%(OR 0.39,95%CI 0.29-0.53,P<0.00001)。6个月死亡率ICPm组32% vs 39.6%(OR 0.76,95%CI 0.61-0.94,P=0.01),排除脑室内出血后29.1% vs 47.2%(OR 0.45,95%CI 0.34-0.60,P<0.0001);6个月功能结局两组无显著差异。颅内压升高与3个月死亡率升高(OR 1.12,95%CI 1.07-1.18,P<0.00001)及良好功能结局可能性降低(OR 1.11,95%CI 1.04-1.18,P<0.00001)相关。
要点
- ICPm组院内死亡率24.9% vs 未监测组34.1%(OR 0.51,95%CI 0.20-1.31,P=0.16),差异无统计学显著性。
- 排除脑室内出血患者后,ICPm组院内死亡率23.5% vs 43%(OR 0.39,95%CI 0.29-0.53,P<0.00001),显著降低。
- 6个月死亡率ICPm组32% vs 39.6%(OR 0.76,95%CI 0.61-0.94,P=0.01);排除脑室内出血后29.1% vs 47.2%(OR 0.45,95%CI 0.34-0.60,P<0.0001);6个月功能结局两组无显著差异。
核心结论
- 颅内压升高与自发性脑出血患者死亡率升高及预后不良相关。
- 持续颅内压监测可能降低特定亚组脑出血患者的短期死亡率,但不改善神经功能结局。
- 作者认为部分患者人群可能从颅内压监测中获益,但需更多研究筛选适合颅内压监测的人群。
研究设计与样本
- 系统综述与Meta分析,纳入接受颅内压监测治疗的自发性脑出血患者,比较ICPm组与未监测组。
- 主要结局为6个月死亡率和院内死亡率,次要结局为6个月神经功能不良结局。
主要发现
- ICPm组院内死亡率24.9% vs 未监测组34.1%(OR 0.51,95%CI 0.20-1.31,P=0.16),差异无统计学显著性。
- 排除脑室内出血患者后,ICPm组院内死亡率23.5% vs 未监测组43%(OR 0.39,95%CI 0.29-0.53,P<0.00001),显著降低。
- 6个月死亡率ICPm组32% vs 未监测组39.6%(OR 0.76,95%CI 0.61-0.94,P=0.01),显著降低;排除脑室内出血后29.1% vs 47.2%(OR 0.45,95%CI 0.34-0.60,P<0.0001)。
- 6个月功能结局两组无统计学显著差异。
- 颅内压升高与3个月死亡率升高(OR 1.12,95%CI 1.07-1.18,P<0.00001)及良好功能结局可能性降低(OR 1.11,95%CI 1.04-1.18,P<0.00001)相关。
临床怎么用
- 作者认为部分脑出血患者人群可能从颅内压监测中获益,但需更多研究筛选适合颅内压监测的人群。
- 原文未据此给出推荐。
局限性
- 作者指出需更多研究来筛选适合颅内压监测的患者人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the potential effects of Intracranial pressure monitoring on the outcome of patients with spontaneous intracerebral hemorrhage (ICH). METHODS: This study is a systematic review with meta-analysis. Patients with spontaneous ICH treated with intracranial pressure monitoring were included. The primary outcome was mortality at 6 months and in-hospital mortality. The secondary outcome was poor neurological function outcome at 6 months. RESULTS: This analysis compares in-hospital and 6-month mortality rates between patients with intracranial pressure monitoring (ICPm) and those without (no ICPm). Although the ICPm group had a lower in-hospital mortality rate, it was not statistically significant (24.9% vs. 34.1%; OR 0.51, 95% CI 0.20 to 1.31, P = 0.16). Excluding patients with intraventricular hemorrhage revealed a significant reduction in in-hospital mortality for the ICPm group (23.5% vs. 43%; OR 0.39, 95% CI 0.29 to 0.53, P < 0.00001). For 6-month mortality, the ICPm group showed a significant reduction (32% vs. 39.6%; OR 0.76, 95% CI 0.61 to 0.94, P = 0.01), with the effect being more pronounced after excluding intraventricular hemorrhage patients (29.1% vs. 47.2%; OR 0.45, 95% CI 0.34 to 0.60, P < 0.0001). However, there were no statistically significant differences in 6-month functional outcomes between the groups. Increased ICP was associated with higher 3-month mortality (OR 1.12, 95% CI 1.07 to 1.18, P < 0.00001) and lower likelihood of good functional outcomes (OR 1.11, 95% CI 1.04 to 1.18, P < 0.00001). CONCLUSIONS: Elevated ICP is associated with increased mortality and poor prognosis in ICH patients. Although continuous intracranial pressure monitoring may reduce short-term mortality rates in specific subgroups of ICH patients, it does not improve neurological functional outcomes. While potential patient populations may benefit from ICP monitoring, more research is needed to screen suitable populations for ICP monitoring.
引用
- Duan S, Yuan Q, Wang M, et al. Intracranial Pressure Monitoring in Patients with Spontaneous Intracerebral Hemorrhage: A Systematic Review with Meta-Analysis. World Neurosurg. 2024. PMID: 38972383. doi:10.1016/j.wneu.2024.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。